biote Corp.

NASDAQ:BTMD

Medical - Care Facilities

Healthcare
$1.23 +0.22%

+$0.01 today

Market cap
$54.25M
Beta
1.66
P/E (TTM)
4.5
EPS (TTM)
$0.51
52W Low $1.27High $4.75

Volume 0.11M

Average 0.25M

BTMD Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

biote Corp.NASDAQ: BTMD

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) dips below year-ago levels

Q1 FY2026 weighted avg shares (diluted) of 36M shares fell 2.6% year over year, behind the +0.7% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 16.8% from the prior quarter. Over 3 fiscal years it compounded at +65.7% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -2.6% toward the trailing-twelve-month pace of +0.7%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
36M+16.8% QoQ
Last fiscal yearDec 2025
36.67M+7.0% YoY
LTMMar 2026
35.12M+0.7% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-2.6%——
1 year+7.0%——
3-year CAGR+65.7%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
36.67M USD
Year-over-year change
+7.0%
4-year CAGR
+48.3%

Weighted Avg Shares (Diluted) vs competitors

How BTMD compares with its peers on the latest reported figures

  • BTMD's LTM Mar 2026 weighted avg shares (diluted) of 35.12M shares is the 5th highest of the 11 companies compared; the peer median is 18.42M shares.
  • Its year-over-year change of +0.7% is the 9th highest of 11, against a peer median of +11.5%.
  • Over three fiscal years its annual growth of +65.7% compares with a peer median of +17.1%.
BTMD Competitors Peer median
Weighted Avg Shares (Diluted) for BTMD and competitors
Company Period LTM YoY 3-year CAGR
INOInovio Pharmaceuticals, Inc.LTM Mar 2026312.72M +1040.7%+186.8%
LUCDLucid Diagnostics Inc.LTM Mar 2026102.76M +82.6%+41.3%
ABOSAcumen Pharmaceuticals, Inc.LTM Mar 202661.23M +1.8%+14.3%
SPROSpero Therapeutics, Inc.LTM Mar 202657.24M +5.3%+16.2%
BTMDbiote Corp.LTM Mar 202635.12M +0.7%+65.7%
ACTUActuate Therapeutics IncLTM Mar 202621.96M +12.5%+11.8%
JYNTThe Joint Corp.LTM Mar 202614.89M -1.2%+0.6%
ANIKAnika Therapeutics, Inc.LTM Mar 202614.25M -2.8%-0.5%
SCLXScilex Holding CompanyLTM Mar 202610.28M +60.8%+42.2%
MCRBSeres Therapeutics, Inc.LTM Mar 20268.99M +10.4%+18.0%
VORVor Biopharma Inc.LTM Mar 20265.81M +40.8%+70.9%
Peer median (excluding BTMD) 18.42M+11.5%+17.1%

Competitors are the stored peer set for BTMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue139.4M164.96M185.36M197.19M192.22M
Cost of Revenue48.82M54.58M57.88M58.13M58.13M
Gross Profit90.58M110.38M127.48M139.06M134.09M
Gross Margin65.0%66.9%68.8%70.5%69.8%
Research & Development00000
Selling, General & Admin53.96M171.1M98.83M107.45M94.97M
Operating Expenses56.02M171.1M98.83M107.45M94.97M
Depreciation & Amortization1.4M2.2M794K3.57M3.67M
EBITDA35.98M7.96M39.54M15.59M53.12M
EBITDA Margin25.8%4.8%21.3%7.9%27.6%
Operating Income34.56M(60.72M)28.66M31.61M39.12M
Operating Margin24.8%-36.8%15.5%16.0%20.4%
Interest Income0000900K
Interest Expense1.67M4.05M6.36M11M11.86M
Other Income / Expenses(1.66M)62.43M(28.78M)(30.6M)(1.54M)
Income Before Tax32.91M1.71M(123K)1.02M37.58M
Pre-Tax Margin23.6%1.0%-0.1%0.5%19.6%
Income Tax Expense286K388K2.68M970K5.99M
Net Income32.62M(969K)3.32M3.16M27.05M
Net Margin23.4%-0.6%1.8%1.6%14.1%
EPS (Basic)(0.87)0.160.130.090.86
EPS (Diluted)(0.87)0.160.130.090.74
Weighted Avg Shares7.57M8.06M25.71M34.27M31.28M
Weighted Avg Shares (Diluted)7.57M8.06M25.71M34.27M36.67M

biote Corp.

NASDAQ:BTMD

Intrinsic Alpha fair value

Locked

Current Price

$1.23

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.